A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas
Clinical trial NCT04917861 · COMPLETED
Trial details
- NCT number
- NCT04917861
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2024-07-26
- Enrollment
- 808
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.